BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 35128676)

  • 21. The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
    Crofford LJ; Nyhoff LE; Sheehan JH; Kendall PL
    Expert Rev Clin Immunol; 2016 Jul; 12(7):763-73. PubMed ID: 26864273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic interdependence of Lyn and negative regulators of B cell receptor signaling in autoimmune disease development.
    Tsantikos E; Maxwell MJ; Kountouri N; Harder KW; Tarlinton DM; Hibbs ML
    J Immunol; 2012 Aug; 189(4):1726-36. PubMed ID: 22798664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell receptor signaling-based index as a biomarker for the loss of peripheral immune tolerance in autoreactive B cells in rheumatoid arthritis.
    Lyubchenko T; Zerbe GO
    PLoS One; 2014; 9(7):e102128. PubMed ID: 25057856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of autoreactive B cells: checkpoints and activation.
    Ding C; Yan J
    Arch Immunol Ther Exp (Warsz); 2007; 55(2):83-9. PubMed ID: 17347802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant B Cell Signaling in Autoimmune Diseases.
    Corneth OBJ; Neys SFH; Hendriks RW
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoreactivity and the positive selection of B cells.
    Übelhart R; Jumaa H
    Eur J Immunol; 2015 Nov; 45(11):2971-7. PubMed ID: 26350303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease.
    Ono C; Tanaka S; Myouzen K; Iwasaki T; Ueda M; Oda Y; Yamamoto K; Kochi Y; Baba Y
    Front Immunol; 2023; 14():1276014. PubMed ID: 37841260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity.
    Szodoray P; Stanford SM; Molberg Ø; Munthe LA; Bottini N; Nakken B
    J Allergy Clin Immunol; 2016 Sep; 138(3):839-851.e8. PubMed ID: 27056269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B cell receptor signaling and autoimmunity.
    Hasler P; Zouali M
    FASEB J; 2001 Oct; 15(12):2085-98. PubMed ID: 11641235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of autoreactive B cells by anergy: a fresh perspective.
    Gauld SB; Merrell KT; Cambier JC
    Curr Opin Immunol; 2006 Jun; 18(3):292-7. PubMed ID: 16616480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications.
    Solouki S; August A; Huang W
    Pharmacol Ther; 2019 Sep; 201():39-50. PubMed ID: 31082431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of self-reactive B cells and autoimmune diseases.
    Burrows PD; Suematsu S; Watanabe T
    Rev Immunogenet; 2000; 2(1):38-51. PubMed ID: 11324692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells.
    Bonasia CG; Abdulahad WH; Rutgers A; Heeringa P; Bos NA
    Cells; 2021 May; 10(5):. PubMed ID: 34068035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T Lymphocytes and Autoimmunity.
    Khan U; Ghazanfar H
    Int Rev Cell Mol Biol; 2018; 341():125-168. PubMed ID: 30262031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Checkpoints controlling the induction of B cell mediated autoimmunity in human autoimmune diseases.
    Reijm S; Kissel T; Toes REM
    Eur J Immunol; 2020 Dec; 50(12):1885-1894. PubMed ID: 33152108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.
    Liubchenko GA; Appleberry HC; Holers VM; Banda NK; Willis VC; Lyubchenko T
    J Autoimmun; 2012 Jun; 38(4):293-303. PubMed ID: 22365785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells.
    Getahun A; Beavers NA; Larson SR; Shlomchik MJ; Cambier JC
    J Exp Med; 2016 May; 213(5):751-69. PubMed ID: 27114609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-cell receptor signaling in lymphoid malignancies and autoimmunity.
    Avalos AM; Meyer-Wentrup F; Ploegh HL
    Adv Immunol; 2014; 123():1-49. PubMed ID: 24840946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice.
    Wang YH; Diamond B
    J Clin Invest; 2008 Aug; 118(8):2896-907. PubMed ID: 18636122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies.
    Meffre E; O'Connor KC
    Immunol Rev; 2019 Nov; 292(1):90-101. PubMed ID: 31721234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.